№ lp_1_2_43949
File format: docx
Character count: 19486
File size: 242 KB
Clinical policy governing out-of-hours dispensing of medicines within mental health services, defining legal, professional and procedural requirements for prescribing, dispensing, administration, and supervision of self-administration.
Version number:
6.0
Document type:
Policy
Subject area:
Medicines management
Scope:
Out-of-hours dispensing of medicines
Applicable services:
Home Treatment Teams; Inpatient wards; Mental health hubs
Organisation scope:
Trust wide
Author:
Chief Pharmacist
Executive director lead:
Chief Medical Director
Consultation groups:
Medicines Committee; Nurse Advisory Council; Clinical Risk Group; Home Treatment Teams
Approved by:
Medicines Committee
Ratified by:
Medicines Committee
Date ratified:
October 2023
Implementation date:
October 2023
Last review date:
October 2023
Next review date:
October 2023
First issued:
August 2005
Regulatory references:
NMC Standards for medicines management; Good Practice in Prescribing Medicines (September 2008)
Target staff groups:
Nurses; Prescribers; Non-medical prescribers; Advanced clinical practitioners
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Region / City:
Bernalillo County
Theme:
Air Quality, Environmental Regulations
Document Type:
Application Form
Agency / Institution:
City of Albuquerque
Target Audience:
Facility owners, operators, and applicants for AQN
Certification:
Signed by responsible officer
Year Issued:
2025
Region / State:
South Carolina
Type of Document:
Request for Proposal (RFP)
Issuing Agency:
SC Department of Public Health, State Fiscal Accountability Authority
Procurement Officer:
Kayla Middleton
Phone:
803-737-2609
Email:
[email protected]
Mailing Address:
SFAA, Div. of Procurement Services, 1333 Main St., Suite 700, Columbia SC 29201-3734
Submission Deadline:
December 22, 2025, 11:00 AM ET
Pre-Bid Conference Date:
November 5, 2025, 12:00 PM ET, Online via Microsoft Teams
Questions Deadline:
November 7, 2025, 12:00 PM ET
Contract Estimated Start Date:
April 1, 2026
Contract Estimated End Date:
June 11, 2030
Maximum Contract Period:
4 years, 2 months (initial 2-year term with two 1-year renewal options)
Number of Copies:
One online submission and one optional redacted copy
Document Sections:
Scope of Solicitation, Instructions to Offerors, Scope of Work/Specifications, Submission Requirements, Qualifications, Award Criteria, Terms and Conditions, Bidding Schedule, Attachments
Document type:
Clinical guideline
Organisation:
Australian Medical Assistance Team (AUSMAT)
Context:
Emergency Medical Team (EMT) Type 1 and 2 field hospitals and specialist cells
Jurisdiction:
Australia
Regulatory basis:
Australian legislation
Scope:
Prescribing, dispensing and administration of medicines
Target personnel:
Medical officers, pharmacists, nurses, midwives, paramedics
Medicine charts:
National Inpatient Medication Chart (NIMC), Patient Treatment Card
Restricted medicines:
Schedule 8 (S8), Schedule 4R (S4R)
IV administration guidance:
Gravity infusion and limited pump use
Reference standards:
WHO Classification and Minimum Standards for Emergency Medical Teams
Document owner:
Medical Director
Date last reviewed:
March 2023
Next review date:
March 2025
Supporting resources:
Australian Injectable Drugs Handbook; Paediatric Injectable Guidelines
Year:
2021
Region / city:
Victoria, Australia
Theme:
Pharmacist regulations
Document type:
Legislative guideline
Agency / institution:
Medicines and Poisons Regulation (MPR)
Author:
Medicines and Poisons Regulation (MPR)
Target audience:
Health practitioners, pharmacists
Period of validity:
Ongoing
Approval date:
2017
Date of amendments:
2021
Context:
This document provides guidelines for pharmacists regarding the dispensing, administration, and supply of Schedule 4 and 8 medicines in Victoria, Australia, as outlined in the Drugs Poisons and Controlled Substances Act 1981 and related regulations.
Year:
2026
Region / city:
Not specified
Subject:
Petroleum storage and dispensing standards
Document type:
Planning scheme policy
Issuing authority:
Local Council
Target audience:
Developers, planners, environmental compliance officers
Purpose:
Mitigate risks of surface water, groundwater, and air pollution from petroleum storage and dispensing
Standards referenced:
AS 1940, AS 1692, UL 1316, USEPA 40 CFR Part 280
Content sections:
Introduction, Standards, Terminology, Surface and groundwater protection, Air quality standards, Vapour recovery systems
Year:
2021
Region / City:
South Africa
Topic:
Nuclear Energy, Bidding Process, Radiopharmaceutical Equipment
Document Type:
Invitation to Bid
Organization / Institution:
South African Nuclear Energy Corporation (Necsa)
Author:
Not specified
Target Audience:
Bidders for the specified project
Validity Period:
90 Days
Approval Date:
Not specified
Amendment Date:
Not specified
Clarification Session Date:
17 January 2022
Closing Date:
08 February 2022
Closing Time:
11:00 am
Contact Person:
Mr. Buyani Nsibande
Contact Email:
[email protected]
Contact Phone:
+27 (0) 12 305 6072
Year:
2022
Country:
United States
Program:
Medicare Drug Price Negotiation Program
Legal authority:
Inflation Reduction Act of 2022 (P.L. 117-169)
Statutory basis:
Social Security Act sections 1191–1198
Administering agency:
Centers for Medicare & Medicaid Services
Document type:
Enrollment form appendix
Subject:
Enrollment of dispensing entities and third-party support entities in the MTF Data Module
Covered drugs:
Selected high-expenditure single source drugs under Medicare Part B and Part D
Price concept:
Maximum Fair Price
Applicable period:
Initial price applicability year 2027
Related systems:
Medicare Transaction Facilitator Data Module
Intended filers:
Dispensing entities and third-party support entities
Submission method:
Medicare Transaction Facilitator Data Module
Regulatory guidance referenced:
Medicare Drug Price Negotiation Program Final Guidance
Year:
2023
Region / City:
UK
Subject:
Pharmacy Technician Training
Document Type:
Log
Organization:
Pearson Education
Author:
Pearson
Target Audience:
Pharmacy Technicians in training
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Context:
A log template for documenting dispensing errors and their verification by final checkers as part of a pharmacy technician diploma course.
Year:
2019
Region / City:
Oregon
Topic:
Medical countermeasures, public health emergency response
Document Type:
Field Operations Guide
Organization:
Oregon Health Authority
Author:
Oregon Medical Countermeasure Workgroup
Target Audience:
Local Public Health Authorities, Tribes, Public Health Personnel
Effective Period:
2019 and ongoing
Approval Date:
January 2019
Modification Date:
Not specified
Year:
2025-2026
Note:
Region / City
Topic:
COVID-19 Vaccination
Document Type:
Medical Procedure
Target Audience:
Healthcare Providers
Period of Validity:
2025-2026
Context:
Medical procedure for healthcare professionals detailing the protocols for dispensing and administering COVID-19 vaccines.
Year:
2022
Region / city:
Lebanon, PA
Topic:
Medical Equipment Procurement
Document Type:
Solicitation/Contract Order
Agency:
Department of Veterans Affairs, Network Contracting Office 4
Author:
Jennifer Beiswenger
Target audience:
Contractors, Vendors
Period of validity:
December 9, 2022
Approval Date:
December 9, 2022
Amendment Date:
N/A
Year:
2019
Region / City:
Maryland, Florida, Texas, California
Subject:
Continuing Education, Physician Dispensing, Controlled Substances
Document Type:
Educational Course List
Organization:
Dental Board
Author:
Not specified
Target Audience:
Physicians, Dentists
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
5/30/19
Note:
Year
Theme:
Healthcare, Oncology, Pharmaceutical Services
Document Type:
Agreement
Year:
2023
Region / City:
Wales
Theme:
Optometry Services
Document Type:
Official Statement
Organization / Institution:
Welsh Government, NHS Wales
Author:
Not specified
Target Audience:
Optometrists, Dispensing Opticians, Optometry Practice Managers
Effective Period:
September/October 2023 onwards
Approval Date:
Not specified
Amendment Date:
Not specified
Note:
Contextual Description
Year:
2022
Region / City:
Haverthwaite
Subject:
Dispensing of Medicines
Document Type:
Policy
Organization / Institution:
Haverthwaite Surgery
Author:
Not specified
Target Audience:
Staff, Patients
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / city:
Australia
Subject:
Pharmaceutical compounding guidelines
Document Type:
Guideline
Organization / Institution:
Pharmacy Board of Australia
Author:
Pharmacy Board of Australia
Target Audience:
Registered pharmacists, education providers, employers
Period of validity:
Indefinite
Approval Date:
Not specified
Date of amendments:
Not specified
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Organisation:
Canberra Health Services
Document type:
Guideline
Reference number:
CHS25/225
Jurisdiction:
Australian Capital Territory
Healthcare setting:
Public health services
Subject area:
Medication management
Professional scope:
Nursing and midwifery practice
Approved by:
Drug and Therapeutics Committee
Target professionals:
Registered nurses and registered midwives
Patient groups:
Adults, children 12 years or older, and selected medicines for children under 12 years
Exclusions:
Neonates, Special Care Nursery patients, Neonatal Intensive Care Unit patients
Regulatory framework:
Australian medicines scheduling (Schedules 2, 3, 4, and 8)
Content components:
Governance, safe use, documentation, approved medicine lists
Year:
2023
Region / city:
European Union
Topic:
Pharmaceutical technology development
Document type:
Briefing document
Organization:
European Medicines Agency
Author:
Not specified
Target audience:
Pharmaceutical experts, regulatory authorities
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
This document is a briefing source for discussing pharmaceutical technology and regulatory aspects at a QIG 1:
1 meeting.
Year:
2023
Country:
Australia
Topic:
Opioid dependence treatment
Document type:
Information overview
Program:
ODT Community Pharmacy Program
Administering body:
Pharmacy Programs Administrator
Related scheme:
Pharmaceutical Benefits Scheme
Legislative framework:
National Health (Highly specialised drugs program) Special Arrangement 2021
Target audience:
Community pharmacists and hospital pharmacists
Effective date:
1 July 2023
Funding period:
2023–24 to 2026–27
Medicines covered:
Methadone, buprenorphine, buprenorphine with naloxone
Regulatory classification:
Schedule 8 controlled drugs
Source type:
Government health program guidance